CoChat

Association between Antidepressants and Dementia Risk in Older Adults with Depression: A Systematic Review and Meta-Analysis

Open access
Wang, Grace Hsin-Min, Li, Piaopiao, Wang, Yehua, Guo, Jingchuan, Wilson, Debbie L., Lo-Ciganic, Wei-Hsuan · 2023 · Journal of Clinical Medicine

The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.

Abstract

Depression, commonly treated with antidepressants, is associated with an increased risk of dementia, especially in older adults. However, the association between antidepressant use and dementia risk is unclear. We searched for randomized controlled trials and observational studies from PubMed, Embase, and Cochrane on 1 February 2022, restricting to full texts in English. Since dementia is a chronic disease requiring a long induction time, we restricted studies with ≥1 year follow-up. We extracted the relative risk (RR) adjusted for the most variables from each study and evaluated the heterogeneity using I square (I2). The protocol was registered in the PROSPERO International Register of Systematic Reviews (CRD42022338038). We included six articles in the systematic review, of which the sample size ranged from 716 to 141,740, and the median length of follow-up was 5 years. The pooled RR was 1.21 (95% CI = 1.12–1.29) with an I2 of 71%. Our findings suggest that antidepressant use was associated with an increased risk of dementia in older adults with depression, yet moderate to high heterogeneity existed across studies. Future work accounting for the depression progression is needed to differentiate the effect of depression and antidepressants on dementia risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm12196342

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart showing the study selection process. In total, 2599 articles were identified using the aforementioned search strategies from the three databases (Embase n = 1546, PubMed n = 748, Cochrane n = 305). After excluding 798 duplicates, 1801 studies were screened for the title and abstract. We then excluded 9 reviews, 1 study with irrelevant contents, 12 articles with a follow-up period of less than 1 year, 5 duplicates of included studies, 14 articles without full text, 3 articles without RR/OR/HR or 95% CI reported, and 4 articles not using non-users as the comparator. Eventually, this systematic review and meta-analysis included 6 studies.
Figure 1 Flowchart showing the study selection process. In total, 2599 articles were identified using the aforementioned search strategies from the three databases (Embase n = 1546, PubMed n = 748, Cochrane n = 305). After excluding 798 duplicates, 1801 studies were screened for the title and abstract. We then excluded 9 reviews, 1 study with irrelevant contents, 12 articles with a follow-up period of less than 1 year, 5 duplicates of included studies, 14 articles without full text, 3 articles without RR/OR/HR or 95% CI reported, and 4 articles not using non-users as the comparator. Eventually, this systematic review and meta-analysis included 6 studies.CC BY · PubMed Central
Figure 2 Funnel plot of the included studies. The white circles indicate the RR in each study (RR), and the dashed line indicates the pooled risk ratio across these studies. RR of the included studies are symmetric around this dashed line.
Figure 2 Funnel plot of the included studies. The white circles indicate the RR in each study (RR), and the dashed line indicates the pooled risk ratio across these studies. RR of the included studies are symmetric around this dashed line.CC BY · PubMed Central
Figure 3 The pooled estimates of the association between antidepressant use and the risk of dementia. The red dot indicates the point estimate of the risk ratio (RR), and the black line indicates the confidence interval (CI). The pooled RR was 1.21 (95% CI 1.12–1.29), indicating that the use of antidepressants was associated with an increased risk of dementia. The heterogeneity across the included studies was moderate to high (I2 = 71%) [36,37,38,39,40,41].
Figure 3 The pooled estimates of the association between antidepressant use and the risk of dementia. The red dot indicates the point estimate of the risk ratio (RR), and the black line indicates the confidence interval (CI). The pooled RR was 1.21 (95% CI 1.12–1.29), indicating that the use of antidepressants was associated with an increased risk of dementia. The heterogeneity across the included studies was moderate to high (I2 = 71%) [36,37,38,39,40,41].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Wiese, 2011, Geriatric depression: The use of antidepressants in the elderly, BC Med. J., 53, 341

Cited by

See all 23

Metadata

Authors
Wang, G. H.-M., Li, P., Wang, Y., Guo, J., Wilson, D. L., & Lo-Ciganic, W.-H.
Affiliations
  • University of Florida (US)
  • Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2023-10-03
Volume
12
Issue
19
Pages
6342
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4387301669
Cited by
23
References
47
Citations by year
2026: 7 · 2025: 9 · 2024: 7
FWCI
1.05
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
antidepressants, dementia risk, depression, older adults, drug safety, cognitive decline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.